Created in 2014 (United States), TAVSCENZA own 19 sister brands and 2214 competing brands. TAVSCENZA is owned by Biomarin Pharmaceutical, listed on the stock exchange of New York The sector of TAVSCENZA is Biotechnology.
Investment simulator :
Portfolio valuation
Biomarin Pharmaceutical
(TAVSCENZA)
over 5 years*
USD 77.29